US BANCORP \DE\ - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q2 2021$1,0000.0%1110.0%0.00%
Q1 2021$1,000
-75.0%
1110.0%0.00%
Q4 2020$4,000
-20.0%
111
-69.2%
0.00%
Q3 2020$5,000
-16.7%
3600.0%0.00%
Q2 2020$6,000
+100.0%
3600.0%0.00%
Q1 2020$3,0003600.00%
Other shareholders
LUMOS PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Lion Point Capital, LP 407,192$5,627,0001.23%
Opaleye Management Inc. 240,892$3,329,0000.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 936,291$12,940,0000.32%
NEA Management Company, LLC 526,663$7,278,0000.31%
Investors Financial Group, LLC 21,766$301,0000.22%
Wealth Advisors of Iowa, LLC 11,760$163,0000.11%
Blackstone Inc. 468,145$6,470,0000.02%
Jefferies Group LLC 120,651$1,667,0000.02%
Texas Yale Capital Corp. 16,000$221,0000.02%
Prospera Financial Services Inc 1,088$15,0000.01%
View complete list of LUMOS PHARMA INC shareholders